XBIO
Xenetic Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.67
+0.86%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.41
- EPS estimate
- —
- Revenue actual
- $660.6K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +30.0%
- Revenue beats (12Q)
- 6
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026